Flagellin attenuates experimental sepsis in a macrophage-dependent manner

Sepsis is the leading cause of death among critically ill patients, and no specific therapeutic agent is currently approved for the treatment of sepsis.

Source: Critical Care - April 3, 2019 Category: Intensive Care Authors: Xiaoliang Yang, Yibing Yin, Xingxing Yan, Zebo Yu, Yi Liu and Ju Cao Tags: Research Source Type: research